Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernardo Bonanni

Showing results (91-100 of 265) with videos related to

Pageof 27
Sort By:
Breast Cancer Research and Treatment|May 10, 2008
Analysis of the presence of cutaneous and mucosal papillomavirus types in ductal lavage fluid, milk and colostrum to evaluate its role in breast carcinogenesisMassimiliano Cazzaniga, Tarik Gheit, Chiara Casadio, et al.
The Pharmacogenomics Journal|April 11, 2019
Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancerHarriet Johansson, Valentina Aristarco, Sara Gandini, et al.
Journal of Cancer Research and Clinical Oncology|November 19, 2015
Improved health perception after genetic counselling for women at high risk of breast and/or ovarian cancer: construction of new questionnaires--an Italian exploratory studyChiara Catania, Irene Feroce, Monica Barile, et al.
Lancet (London, England)|December 17, 2013
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trialJack Cuzick, Ivana Sestak, John F Forbes, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 2, 2016
A Randomized, Placebo-Controlled, Phase II, Presurgical Biomarker Trial of Celecoxib Versus Exemestane in Postmenopausal Breast Cancer PatientsValentina Aristarco, Davide Serrano, Sara Gandini, et al.
Cancer|August 27, 2004
Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institutionMattia Intra, Nicole Rotmensz, Giuseppe Viale, et al.
Breast Cancer Research and Treatment|January 30, 2007
Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysisDebora Macis, Patrick Maisonneuve, Harriet Johansson, et al.
Journal of Translational Medicine|December 29, 2022
Metabolomic profiles of metformin in breast cancer survivors: a pooled analysis of plasmas from two randomized placebo-controlled trialsFederica Bellerba, Anastasia Chrysovalantou Chatziioannou, Paniz Jasbi, et al.
Cancers|May 14, 2025
Germline Testing in Breast Cancer: A Single-Center Analysis Comparing Strengths and Challenges of Different ApproachesMonica Marabelli, Mariarosaria Calvello, Elena Marino, et al.
Cancers|April 13, 2024
Prognostic Value of <i>PCSK9</i> Levels in Premenopausal Women at Risk of Breast Cancer-Evidence from a 17-Year Follow-Up StudyMassimiliano Ruscica, Chiara Macchi, Sara Gandini, et al.
Pageof 27

Showing results (91-100 of 265) with videos related to

Sort By:
Pageof 27
Breast Cancer Research and Treatment|May 10, 2008
Analysis of the presence of cutaneous and mucosal papillomavirus types in ductal lavage fluid, milk and colostrum to evaluate its role in breast carcinogenesisMassimiliano Cazzaniga, Tarik Gheit, Chiara Casadio, et al.
The Pharmacogenomics Journal|April 11, 2019
Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancerHarriet Johansson, Valentina Aristarco, Sara Gandini, et al.
Journal of Cancer Research and Clinical Oncology|November 19, 2015
Improved health perception after genetic counselling for women at high risk of breast and/or ovarian cancer: construction of new questionnaires--an Italian exploratory studyChiara Catania, Irene Feroce, Monica Barile, et al.
Lancet (London, England)|December 17, 2013
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trialJack Cuzick, Ivana Sestak, John F Forbes, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 2, 2016
A Randomized, Placebo-Controlled, Phase II, Presurgical Biomarker Trial of Celecoxib Versus Exemestane in Postmenopausal Breast Cancer PatientsValentina Aristarco, Davide Serrano, Sara Gandini, et al.
Cancer|August 27, 2004
Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institutionMattia Intra, Nicole Rotmensz, Giuseppe Viale, et al.
Breast Cancer Research and Treatment|January 30, 2007
Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysisDebora Macis, Patrick Maisonneuve, Harriet Johansson, et al.
Journal of Translational Medicine|December 29, 2022
Metabolomic profiles of metformin in breast cancer survivors: a pooled analysis of plasmas from two randomized placebo-controlled trialsFederica Bellerba, Anastasia Chrysovalantou Chatziioannou, Paniz Jasbi, et al.
Cancers|May 14, 2025
Germline Testing in Breast Cancer: A Single-Center Analysis Comparing Strengths and Challenges of Different ApproachesMonica Marabelli, Mariarosaria Calvello, Elena Marino, et al.
Cancers|April 13, 2024
Prognostic Value of <i>PCSK9</i> Levels in Premenopausal Women at Risk of Breast Cancer-Evidence from a 17-Year Follow-Up StudyMassimiliano Ruscica, Chiara Macchi, Sara Gandini, et al.
Pageof 27